These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 22343384)

  • 21. [Effect of biological prognostic factors on therapy of non-seminomatous stage I testicular tumors--an assessment of the current status].
    Kuczyk MA; Bokemeyer C; Serth J; Machtens S; Höfner K; Jonas U
    Urologe A; 1996 Jan; 35(1):35-45. PubMed ID: 8851847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and treatment of urological malignancy: the testes.
    Wilkins M; Horwich A
    Br J Hosp Med; 1996 Feb 21-Mar 5; 55(4):199-203. PubMed ID: 8777501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of low-stage nonseminomatous germ cell tumors of testis: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009.
    Stephenson AJ; Aprikian AG; Gilligan TD; Oldenburg J; Powles T; Toner GC; Waters WB
    Urology; 2011 Oct; 78(4 Suppl):S444-55. PubMed ID: 21986224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The roles of supernumerical X chromosomes and XIST expression in testicular germ cell tumors.
    Kawakami T; Okamoto K; Sugihara H; Hattori T; Reeve AE; Ogawa O; Okada Y
    J Urol; 2003 Apr; 169(4):1546-52. PubMed ID: 12629412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent developments in testicular germ cell tumor research.
    van de Geijn GJ; Hersmus R; Looijenga LH
    Birth Defects Res C Embryo Today; 2009 Mar; 87(1):96-113. PubMed ID: 19306344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeat retroperitoneal lymph-node dissection after chemotherapy for metastatic testicular germ cell tumour.
    Willis SF; Winkler M; Savage P; Seckl MJ; Christmas TJ
    BJU Int; 2007 Oct; 100(4):809-12. PubMed ID: 17711512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
    Schmidt P; Haas RJ; Göbel U; Calaminus G
    Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneously detected bilateral testicular cancer of different histopathological origin--a challenging situation for the urologist.
    Hammerich KH; Schroeck FR; West D; Moul JW
    Oncology (Williston Park); 2010 Jul; 24(8):757-60. PubMed ID: 20718257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concordance and prediction ability of original and reviewed vascular invasion and other prognostic parameters of clinical stage I nonseminomatous germ cell testicular tumors after retroperitoneal lymph node dissection.
    Nicolai N; Colecchia M; Biasoni D; Catanzaro M; Stagni S; Torelli T; Necchi A; Piva L; Milani A; Salvioni R
    J Urol; 2011 Oct; 186(4):1298-302. PubMed ID: 21849196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retroperitoneal lymph node dissection in the treatment of patients with non-seminoma testicular tumours.
    Kułakowski A; Dardziński R
    Eur J Surg Oncol; 1991 Dec; 17(6):581-4. PubMed ID: 1660411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical management of early-stage nonseminomatous germ cell tumors of the testis.
    Lieskovsky G; Weinberg AC; Skinner DG
    Semin Urol; 1984 Nov; 2(4):208-16. PubMed ID: 6095395
    [No Abstract]   [Full Text] [Related]  

  • 32. Stage I nonseminomatous germ cell tumor of the testis: more questions than answers?
    Powles T
    Hematol Oncol Clin North Am; 2011 Jun; 25(3):517-27,viii. PubMed ID: 21570606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic markers in clinical stage I seminoma and nonseminomatous germ cell tumours.
    Pedraza AM; Stephenson AJ
    Curr Opin Urol; 2018 Sep; 28(5):448-453. PubMed ID: 29979237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified neck dissection for metastatic nonseminomatous testicular carcinoma.
    Weisberger EC; McBride LC
    Laryngoscope; 1999 Aug; 109(8):1241-4. PubMed ID: 10443827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved management of abdominal undescended testicular tumors with bulky confluent retroperitoneal nodal metastases.
    Kulkarni JN; Desai SM; Phadke GK; Tongaonkar HB
    J Urol; 1996 Oct; 156(4):1341-4. PubMed ID: 8808867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant treatment in the management of testis-confined germ cell tumours after orchidectomy.
    Sava T; Consoli F; Santo A; Cetto GL
    BJU Int; 2008 Jan; 101(2):155-9. PubMed ID: 17662077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection.
    Spiess PE; Brown GA; Liu P; Tu SM; Tannir NM; Evans JG; Kamat AM; Kassouf W; Pisters LL
    J Urol; 2007 Jan; 177(1):131-8. PubMed ID: 17162023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of clinical stage I nonseminomatous germ-cell testis tumors.
    Flechon A; Droz JP
    Expert Rev Anticancer Ther; 2003 Feb; 3(1):21-30. PubMed ID: 12597346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilateral testicular germ cell tumors.
    Zingg EJ; Zehntner C
    Prog Clin Biol Res; 1985; 203():673-80. PubMed ID: 3008188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
    Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
    BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.